David Dance, MD
Ophthalmology · Coeur D Alene, IDNPI 1003064577
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,826 of the $4,148 with a category attached, or 68.1%. Glaukos Corporation accounts for 73.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $2,843 and has fallen 97.9% since, to $60 in 2025.
Across 45 payments — averaging $92.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$3K
- Alcon$222
- Regeneron Healthcare Solutions, Inc.$184
- Genentech USA, Inc.$149
- Astellas Pharma US Inc$148
- Rxsight Inc$66
- plus $312 from 10 others
What the payments were for
- Travel & lodging$2,82668%
- Food & beverage$1,32232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 13 | $3,066 |
| Alcon | 5 | $222 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| Genentech USA, Inc. | 2 | $149 |
| Astellas Pharma US Inc | 2 | $148 |
| Rxsight Inc | 3 | $66 |
| Aerie Pharmaceuticals, Inc. | 4 | $61 |
| AbbVie(2 entities) | 2 | $50 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $38 |
| Dompe US, Inc. | 1 | $34 |
| Ivantis, Inc | 1 | $27 |
| Alimera Sciences, Inc. | 1 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Travere Therapeutics, Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GSW-iStentinjectWTrabecular Micro-Bypass System$688
- iStent Inject Trabecular Micro-Bypass System$688
- IACCESS$557
- iStent inject W$557
- Clareon$147
- Izervay$125
- VABYSMO$114
- iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3$103
- iStent infinite Trabecular Micro-Bypass System Model iS3$103
How this compares
$4,148 in reported general payments places this provider in the 85th percentile of 60 ophthalmology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 436 | $6,755 |
| LumiganBimatoprost | 16 | $6,534 |
| Bromfenac Sodium | 49 | $6,153 |
| Prednisolone Acetate | 108 | $4,398 |
| Fluorometholone | 38 | $2,815 |
| Timolol Maleate | 200 | $1,705 |
| ValacyclovirValacyclovir Hcl | 14 | $1,031 |
| Ofloxacin | 55 | $661 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 40 | $605 |
| Brimonidine Tartrate | 75 | $544 |
| Acyclovir | 11 | $404 |
| ErythromycinErythromycin Base | 13 | $398 |
| Dorzolamide Hcl | 14 | $395 |
| Ketorolac Tromethamine | 11 | $152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $50 | $6,53416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 60 ophthalmology providers in Idaho.
Other ophthalmology in Coeur D Alene
- Alison GranierCoeur D Alene$4K
- Golden BucklandCoeur D Alene$2K
- Whitney MyersCoeur D Alene$1K
- Drew ThomasCoeur D Alene$991
- Sara DukeCoeur D Alene$762
- Sonya BlizzardCoeur D Alene$63
- Adam ReynoldsBoise$47K
- Ryan BarrettBoise$7K
- Landon GrangeBoise$5K
- Jacob MongBoise$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.